Biblio

Found 56 results
Author Keyword Title Type [ Year(Asc)]
Filters: Keyword is Genetic Predisposition to Disease  [Clear All Filters]
2021
Le Guen Y, Belloy ME, Napolioni V, Eger SJ, Kennedy G, Tao R, He Z, Greicius MD.  2021.  A novel age-informed approach for genetic association analysis in Alzheimer's disease.. Alzheimers Res Ther. 13(1):72.
2018
Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CHong, Kouri N, Ross OA, Höglinger GU, Müller U et al..  2018.  Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.. PLoS Med. 15(1):e1002487.
Wang M, Beckmann ND, Roussos P, Wang E, Zhou X, Wang Q, Ming C, Neff R, Ma W, Fullard JF et al..  2018.  The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.. Sci Data. 5:180185.
2017
Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al..  2017.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
Deming Y, Li Z, Kapoor M, Harari O, Del-Aguila JL, Black K, Carrell D, Cai Y, Fernández MVictoria, Budde J et al..  2017.  Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.. Acta Neuropathol. 133(5):839-856.
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC et al..  2017.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.. Nat Genet. 49(9):1373-1384.
Jun GR, Chung J, Mez J, Barber R, Beecham GW, Bennett DA, Buxbaum JD, Byrd GS, Carrasquillo MM, Crane PK et al..  2017.  Transethnic genome-wide scan identifies novel Alzheimer's disease loci.. Alzheimers Dement. 13(7):727-738.
Mez J, Chung J, Jun G, Kriegel J, Bourlas AP, Sherva R, Logue MW, Barnes LL, Bennett DA, Buxbaum JD et al..  2017.  Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.. Alzheimers Dement. 13(2):119-129.
2016
Karch CM, Ezerskiy LA, Bertelsen S, Goate AM.  2016.  Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.. PLoS One. 11(2):e0148717.
Sims R, Williams J.  2016.  Defining the Genetic Architecture of Alzheimer's Disease: Where Next.. Neurodegener Dis. 16(1-2):6-11.
Mez J, Mukherjee S, Thornton T, Fardo DW, Trittschuh E, Sutti S, Sherva R, Kauwe JS, Naj AC, Beecham GW et al..  2016.  The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.. Neurobiol Aging. 41:115-121.
Kunkle BW, Jaworski J, Barral S, Vardarajan B, Beecham GW, Martin ER, Cantwell LS, Partch A, Bird TD, Raskind WH et al..  2016.  Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.. Alzheimers Dement. 12(1):2-10.
Ebbert MTW, Boehme KL, Wadsworth ME, Staley LA, Mukherjee S, Crane PK, Ridge PG, Kauwe JSK.  2016.  Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.. Alzheimers Dement. 12(2):121-129.
2015
Reitz C.  2015.  Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.. Expert Rev Mol Diagn. 15(3):339-48.
Malik M, Chiles J, Xi HS, Medway C, Simpson J, Potluri S, Howard D, Liang Y, Paumi CM, Mukherjee S et al..  2015.  Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.. Hum Mol Genet. 24(12):3557-70.
Chen JA, Wang Q, Davis-Turak J, Li Y, Karydas AM, Hsu SC, Sears RL, Chatzopoulou D, Huang AY, Wojta KJ et al..  2015.  A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.. JAMA Neurol. 72(4):414-22.
Rosenthal E, Blue E, Jarvik GP.  2015.  Next-generation gene discovery for variants of large impact on lipid traits.. Curr Opin Lipidol. 26(2):114-9.
2014
Karch CM, Cruchaga C, Goate AM.  2014.  Alzheimer's disease genetics: from the bench to the clinic.. Neuron. 83(1):11-26.
Sonnega A, Faul JD, Ofstedal MBeth, Langa KM, Phillips JWR, Weir DR.  2014.  Cohort Profile: the Health and Retirement Study (HRS).. Int J Epidemiol. 43(2):576-85.
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YSon, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, San Wang L- et al..  2014.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
Li Y, Chen JA, Sears RL, Gao F, Klein ED, Karydas A, Geschwind MD, Rosen HJ, Boxer AL, Guo W et al..  2014.  An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.. PLoS Genet. 10(3):e1004211.
Patel A, Rees SD, M Kelly A, Bain SC, Barnett AH, Prasher A, Arshad H, Prasher VP.  2014.  Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.. BMC Res Notes. 7:42.
Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel J-P, Younkin SG et al..  2014.  Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.. PLoS Genet. 10(9):e1004606.
Guerreiro R, Brás J, Hardy J, Singleton A.  2014.  Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.. Hum Mol Genet. 23(R1):R47-53.